Nanoparticles and antigen delivery: Understanding the benefits and drawbacks of different delivery platforms

Nicholas O Fischer; Amy Rasley; Craig Blanchette

doi:10.2217/nnm.14.16

Nanoparticles and antigen delivery: Understanding the benefits and drawbacks of different delivery platforms

Nicholas O Fischer, Amy Rasley, Craig Blanchette

Research output: Contribution to journal › Article

Original language	English (US)
Pages (from-to)	373-376
Number of pages	4
Journal	Nanomedicine
Volume	9
Issue number	4
DOIs	https://doi.org/10.2217/nnm.14.16
State	Published - 2014
Externally published	Yes

Keywords

adjuvants
immune agonists
immunomodulation
infectious disease
innate immunity
nanoparticles
nanotechnology
subunit vaccines
vaccines

ASJC Scopus subject areas

Materials Science(all)
Bioengineering
Biomedical Engineering
Medicine (miscellaneous)
Development
Medicine(all)

Access to Document

10.2217/nnm.14.16

Cite this

Fischer, N. O., Rasley, A., & Blanchette, C. (2014). Nanoparticles and antigen delivery: Understanding the benefits and drawbacks of different delivery platforms. Nanomedicine, 9(4), 373-376. https://doi.org/10.2217/nnm.14.16

@article{ee46522d74224cc78fd5bfaa8e83de4e,

title = "Nanoparticles and antigen delivery: Understanding the benefits and drawbacks of different delivery platforms",

keywords = "adjuvants, immune agonists, immunomodulation, infectious disease, innate immunity, nanoparticles, nanotechnology, subunit vaccines, vaccines",

author = "Fischer, {Nicholas O} and Amy Rasley and Craig Blanchette",

year = "2014",

doi = "10.2217/nnm.14.16",

language = "English (US)",

volume = "9",

pages = "373--376",

journal = "Nanomedicine",

issn = "1743-5889",

publisher = "Future Medicine Ltd.",

number = "4",

}

TY - JOUR

T1 - Nanoparticles and antigen delivery

T2 - Understanding the benefits and drawbacks of different delivery platforms

AU - Fischer, Nicholas O

AU - Rasley, Amy

AU - Blanchette, Craig

PY - 2014

Y1 - 2014

KW - adjuvants

KW - immune agonists

KW - immunomodulation

KW - infectious disease

KW - innate immunity

KW - nanoparticles

KW - nanotechnology

KW - subunit vaccines

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=84899794217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899794217&partnerID=8YFLogxK

U2 - 10.2217/nnm.14.16

DO - 10.2217/nnm.14.16

M3 - Article

C2 - 24787434

AN - SCOPUS:84899794217

VL - 9

SP - 373

EP - 376

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 4

ER -